The Age of Crispr Medicine Is Here
Feed: All Latest,
The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.
The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.
Ed. Note: This post updates an earlier post from 2018. In a landmark decision today, the Food and Drug Administration (FDA…
Sickled cells occluding a blood vessel. (Image: Elena Hartley)Boston Children’s Hospital is now enrolling patients age 3 to 35…
My lab recently published a paper, together with outstanding co-corresponding authors David Martin (CHORI) and Dana Carroll (Univ…
Sickle cell disease (SCD) is a perfect candidate for gene editing. It is perhaps the best understood single-gene condition, due…
[Corrected 10/13/16, 1:00 p.m. See below.] Another academic group has published results of animal experiments that use the gene…
Sick Papes Interview with Luke Gilbert!We recently received the following letter:Dear Sick Papes,I am a third grader who lives…
Sick Papes Interview with Luke Gilbert!We recently received the following letter:Dear Sick Papes,I am a third grader who lives…
(Digital Storm/Shutterstock)When genome-wide association studies (GWAS) first started appearing 10 years ago, they were…
Rosa’s to like Larry H. Bernstein, MD, FCAP LPBI Reality Check: Cancer Experts Discuss Hurdles Facing CAR-T Therapy http://www.
В свежих номерах популярных научных журн&
Changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease (SCD)…